Acetated Ringer's Solution Versus Saline in Patients With Septic Shock
- Conditions
- Septic Shock Hyperdynamic
- Interventions
- Drug: Fluid resuscitation
- Registration Number
- NCT04507672
- Lead Sponsor
- Southeast University, China
- Brief Summary
The primary aim of this trial is to compare the effect of acetated ringer's solution with that of saline for therapy on the incidence and development of major adverse renal events among septic shock patients. The investigators hypothesize that use of acetated ringer's solution for resuscitation among septic shock patients will reduce the incidence of major adverse kidney events.
- Detailed Description
Normal saline and Ringer's solutions are the preferred crystalloid fluids administered in early septic shock. However, evidence have associated saline with hyperchloremia and secondary metabolic acidosis, and renal vasoconstriction, increased incidence of acute kidney injury (AKI) and mortality. The primary aim of this trial is to compare the effect of acetated ringer's solution with that of saline for therapy on the incidence and development of major adverse renal events among septic shock patients. The investigators hypothesize that use of acetated ringer's solution for resuscitation among septic shock patients will reduce the incidence of major adverse kidney events.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2000
Adult patients presenting to the ICU diagnosed as septic shock within 24 hours.
- Pregnancy;
- Likely requirement for immediate hemodialysis or renal replacement therapy;
- Patients have already received fluids for more than 4 liters;
- Patient in extremis or death deemed imminent and inevitable.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description saline group Fluid resuscitation Use saline for fluid resuscitation during the first 72 hours after enrollment Acetated Ringer's solution group Fluid resuscitation Use acetated Ringer's solution for fluid resuscitation during the first 72 hours after enrollment
- Primary Outcome Measures
Name Time Method Incidence of major adverse renal events in 28 days 28 day Incidence of major adverse renal events
- Secondary Outcome Measures
Name Time Method Incidence of kidney injury 28 day Incidence of kidney injury
Serum creatinine(umol/L) 28 day serum creatinine(umol/L)